Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome

被引:108
作者
Geraghty, Joseph R. [1 ,2 ]
Davis, Joseph L. [1 ]
Testai, Fernando D. [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Neurol & Rehabil, 912 S Wood St,Suite 174N, Chicago, IL 60612 USA
[2] Univ Illinois, Med Sci Training Program, Chicago, IL USA
关键词
Early brain injury; Microvascular dysfunction; Neuroinflammation; Subarachnoid hemorrhage; Vasospasm; DELAYED CEREBRAL-ISCHEMIA; INTERCELLULAR-ADHESION MOLECULE-1; ENDOTHELIN RECEPTOR ANTAGONIST; MAGNESIUM-SULFATE SOLUTION; CEREBROSPINAL-FLUID; NITRIC-OXIDE; NEUROLOGICAL DEFICITS; MONOCLONAL-ANTIBODY; CYCLOSPORINE-A; DOUBLE-BLIND;
D O I
10.1007/s12028-019-00710-x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aneurysmal subarachnoid hemorrhage has a high mortality rate and, for those who survive this devastating injury, can lead to lifelong impairment. Clinical trials have demonstrated that cerebral vasospasm of larger extraparenchymal vessels is not the sole contributor to neurological outcome. Recently, the focus of intense investigation has turned to mechanisms of early brain injury that may play a larger role in outcome, including neuroinflammation and microvascular dysfunction. Extravasated blood after aneurysm rupture results in a robust inflammatory response characterized by activation of microglia, upregulation of cellular adhesion molecules, recruitment of peripheral immune cells, as well as impaired neurovascular coupling, disruption of the blood-brain barrier, and imbalances in endogenous vasodilators and vasoconstrictors. Each of these phenomena is either directly or indirectly associated with neuronal death and brain injury. Here, we review recent studies investigating these various mechanisms in experimental models of subarachnoid hemorrhage with special emphasis on neuroinflammation and its effect on microvascular dysfunction. We discuss the various therapeutic targets that have risen from these mechanistic studies and suggest the utility of a multi-targeted approach to preventing delayed injury and improving outcome after subarachnoid hemorrhage.
引用
收藏
页码:373 / 389
页数:17
相关论文
共 187 条
[81]  
Lesley WS, 2003, AM J NEURORADIOL, V24, P1234
[82]   Hemoglobin induced NO/cGMP suppression Deteriorate Microcirculation via Pericyte Phenotype Transformation after Subarachnoid Hemorrhage in Rats [J].
Li, Qiang ;
Chen, Yujie ;
Li, Bo ;
Luo, Chunxia ;
Zuo, Shilun ;
Liu, Xin ;
Zhang, John H. ;
Ruan, Huaizhen ;
Feng, Hua .
SCIENTIFIC REPORTS, 2016, 6
[83]   Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke [J].
Li, Wentao ;
Xu, Haoliang ;
Testai, Fernando D. .
FRONTIERS IN NEUROLOGY, 2016, 7
[84]   Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage [J].
Lin, Sen ;
Yin, Qing ;
Zhong, Qi ;
Lv, Feng-Lin ;
Zhou, Yu ;
Li, Jing-Qi ;
Wang, Jing-Zhou ;
Su, Bing-yin ;
Yang, Qing-Wu .
JOURNAL OF NEUROINFLAMMATION, 2012, 9
[85]   Ficolin-1 Levels in Patients Developing Vasospasm and Cerebral Ischemia After Spontaneous Subarachnoid Hemorrhage [J].
Llull, Laura ;
Thiel, Steffen ;
Amaro, Sergio ;
Cervera, Alvaro ;
Planas, Anna M. ;
Chamorro, Angel .
MOLECULAR NEUROBIOLOGY, 2017, 54 (08) :6572-6580
[86]   Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review [J].
Lucke-Wold, Brandon P. ;
Logsdon, Aric F. ;
Manoranjan, Branavan ;
Turner, Ryan C. ;
McConnell, Evan ;
Vates, George Edward ;
Huber, Jason D. ;
Rosen, Charles L. ;
Simard, J. Marc .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04) :1-17
[87]   Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control [J].
Luo, C. ;
Yao, X. ;
Li, J. ;
He, B. ;
Liu, Q. ;
Ren, H. ;
Liang, F. ;
Li, M. ;
Lin, H. ;
Peng, J. ;
Yuan, T. F. ;
Pei, Z. ;
Su, H. .
CELL DEATH & DISEASE, 2016, 7 :e2160-e2160
[88]   Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial [J].
Macdonald, R. Loch ;
Kassell, Neal F. ;
Mayer, Stephan ;
Ruefenacht, Daniel ;
Schmiedek, Peter ;
Weidauer, Stephan ;
Frey, Aline ;
Roux, Sebastien ;
Pasqualin, Alberto .
STROKE, 2008, 39 (11) :3015-3021
[89]   Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) [J].
Macdonald, R. Loch ;
Higashida, Randall T. ;
Keller, Emanuela ;
Mayer, Stephan A. ;
Molyneux, Andy ;
Raabe, Andreas ;
Vajkoczy, Peter ;
Wanke, Isabel ;
Bach, Doris ;
Frey, Aline ;
Marr, Angelina ;
Roux, Sebastien ;
Kassell, Neal .
LANCET NEUROLOGY, 2011, 10 (07) :618-625
[90]   A REVIEW OF HEMOGLOBIN AND THE PATHOGENESIS OF CEREBRAL VASOSPASM [J].
MACDONALD, RL ;
WEIR, BKA .
STROKE, 1991, 22 (08) :971-982